Test supplement for low magnesium in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This Phase 2 study tests MLD10 to help people with type 2 diabetes who have low magnesium levels. If you qualify, you may receive the study treatment to see if it improves magnesium-related health in a safe way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- Your body mass index (BMI) is between 18 and 40
- Your blood test shows low magnesium (magnesium 1.5 mg/dL or less)
- If you are female, you are not pregnant or breastfeeding and your pregnancy test is negative
- You do not have major health conditions like serious stomach/intestine, kidney, liver, brain/nerve, blood, immune, or heart problems (other than type 2 diabetes)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a magnesium supplement can raise magnesium levels in red blood cells. It is for adults with low magnesium who are willing to stop other magnesium supplements and get blood drawn.
This trial studies whether giving magnesium helps people who are hospitalized with low magnesium levels. It may help correct low magnesium and improve how patients feel and recover.
This early study tests whether replacing magnesium—either by diet or a topical (skin) supplement—can improve safety or other health measures in people with lymphoma. It focuses on people who have a slightly low magnesium level and checks blood magnesium repeatedly during the study.
This study tests whether a special supplement containing protein, creatine, omega-3, and vitamin D can help stabilize blood sugar levels in Mexican adults with type 2 diabetes. You may be able to join if you take metformin alone or no diabetes medication and meet a few other criteria.
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
Hear when a new Hypomagnesemia in Type 2 Diabetic Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.